Skip to main content

Table 3 Phase II Indicator Selection Criteria

From: Ending preventable maternal mortality: phase II of a multi-step process to develop a monitoring framework, 2016–2030

Relevance • Indicator directly supports EPMM strategies for reducing preventable maternal mortality
• There is evidence that what the indicator measures is significantly associated with improved maternal health and survival
Importance • Indicator resonates, and is valuable to decision makers and stakeholders
• Indicator “makes a difference” for improving maternal health and survival across countries and contexts
Interpretability & Usefulness • There is good/strong evidence to support the process, or the outcome
• Results point to areas for improvement and can advance strategic planning, policy or programming at different levels of the system
Validity • Indicator measures what it is supposed to measure
• Indicator has been field-tested and used
• Indicator makes sense logically and scientifically
Feasibility & Data Availability • Based on the best available data of acceptable quality
• Data can be obtained with reasonable and affordable efforts in timely manner
• Data does not overly increase reporting burden on countries
Harmonization • Indicator strengthens or compliments existing efforts
• Indicator is recommended and being used by leading experts and organizations
• Indicator lacks redundancy and does not measure something already captured under other indicators